Clinically apparent and occult metastasized seminoma: Almost indistinguishable on the transcriptional level

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Ruf, Christian G ^a,b   Port, Matthias ^b,c   Schmelz, Hans Ulrich ^b,d   Wagner, Walter ^a   Müller, Felix ^a,b   Senf, Sven ^b   Matthies, Cord ^a   Müller Myhsok, Bertram ^e   Meineke, Viktor ^b   Abend, Michael ^b  

^a Bundeswehrkrankenhaus Hamburg   (Germany)

^b Bundeswehr Institute of Radiobiology   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d BUNDESWEHRZENTRALKRANKENHAUS KOBLENZ   (Germany)

^e MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA; RNA; SMALL RNA; UNCLASSIFIED DRUG; TRANSCRIPTOME;

APPARENT METASTASIZED SEMINOMA; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; GENE EXPRESSION; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; OCCULT METASTASIZED SEMINOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; SEMINOMA; TRANSCRIPTOMICS; ADOLESCENT; ADULT; CHILD; GENE EXPRESSION PROFILING; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; TESTIS TUMOR; TUMOR VOLUME; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; RNA, MESSENGER; SEMINOMA; TESTICULAR NEOPLASMS; TRANSCRIPTOME; TUMOR BURDEN; YOUNG ADULT;

EID: 84900464374     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095009     Document Type: Article

References (19)

1. Krege S, Beyer J, Souchon R, Albers P, Albrecht W, et al. (2008) European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. European urology 53: 478-496.
2. Ruf CG, Isbarn H, Wagner W, Fisch M, Matthies C, et al. (2013) Changes in epidemiologic features of testicular germ cell cancer: Age at diagnosis and relative frequency of seminoma are constantly and significantly increasing(). Urol Oncol.
3. Albers P, Albrecht W, Algaba F, Bokemeyer C, Cohn-Cedermark G, et al. (2012) [EAU guidelines on testicular cancer: 2011 update. European Association of Urology]. Actas urologicas espanolas 36: 127-145.
4. Kollmannsberger C, Tyldesley S, Moore C, Chi KN, Murray N, et al. (2011) Evolution in management of testicular seminoma: population-based outcomes with selective utilization of active therapies. Ann Oncol 22: 808-814.
5. Valdevenito JP, Gallegos I, Fernandez C, Acevedo C, Palma R (2007) Correlation between primary tumor pathologic features and presence of clinical metastasis at diagnosis of testicular seminoma. Urology 70: 777-780. (Pubitemid 350030216)
6. Warde P, Gospodarowicz MK, Banerjee D, Panzarella T, Sugar L, et al. (1997) Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. The Journal of urology 157: 1705-1709; discussion 1709-1710.
7. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, et al. (2002) Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20: 4448-4452.
8. Ruf CG, Khalili-Harbi N, Sachs S, Isbarn H, Wagner W, et al. (2013) The Search for Biomarkers of Metastatic Seminoma. J Urol.
9. Port M, Wang Y, Schmelz HU, Pottek T, Meineke V, et al. (2011) A gene signature of primary tumor identifies metastasized seminoma. Urologic oncology 29: 764-773.
10. Ruf CG, Linbecker M, Port M, Riecke A, Schmelz HU, et al. (2012) Predicting metastasized seminoma using gene expression. BJU international 110: E14-20.
11. Profumo V, Gandellini P (2013) MicroRNAs: cobblestones on the road to cancer metastasis. Crit Rev Oncog 18: 341-355.
12. Fendler A, Stephan C, Yousef GM, Jung K (2011) MicroRNAs as regulators of signal transduction in urological tumors. Clin Chem 57: 954-968.
13. Chen KS, Amatruda JF (2013) A big catch for germ cell tumour research. PLoS Genet 9: e1003481.
14. Dieckmann KP, Spiekermann M, Balks T, Flor I, Loning T, et al. (2012) MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107: 1754-1760.
15. Murray MJ, Halsall DJ, Hook CE, Williams DM, Nicholson JC, et al. (2011) Identification of microRNAs From the miR-371-373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135: 119-125.
16. Baggerly KA, Deng L, Morris JS, Aldaz CM (2004) Overdispersed logistic regression for SAGE: modelling multiple groups and covariates. BMC Bioinformatics 5: 144.
17. Mette Sakso Mortensen MGG, Jakob Lauritsen, Mads Agerbaek, Niels Vilstrup Holm, Hans von der Maase, et al. (2013) A nationwide cohort study of surveillance for stage I seminoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology J Clin Oncol 31, 2013 (suppl; abstr 4502).
18. von der Maase H, Specht L, Jacobsen GK, Jakobsen A, Madsen EL, et al. (1993) Surveillance following orchidectomy for stage I seminoma of the testis. European journal of cancer 29A: 1931-1934. (Pubitemid 23324346)
19. Port M, Seidl C, Ruf CG, Riecke A, Meineke V, et al. (2012) Reliable and sample saving gene expression analysis approach for diagnostic tool development. Health Phys 103: 159-168.